Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 10/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 6/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23399779 | 0.88 | BCHE (0.51) | KDM4ECYP1A2CYP2D6GAATSHR | |
| SCHEMBL23402925 | 0.87 | ALDH1A1 (0.58) | KDM4ECYP1A2CYP2D6GAATSHR | |
| SCHEMBL537958 | 0.82 | KDM4E (0.69) | KDM4ECYP1A2CYP2D6GAATSHR | |
| SCHEMBL23401512 | 0.82 | ALDH1A1 (0.53) | KDM4ECYP1A2CYP2D6GAATSHR | |
| SCHEMBL23402983 | 0.82 | ALDH1A1 (0.53) | KDM4ECYP1A2CYP2D6GAATSHR | |
| SCHEMBL23403198 | 0.81 | TSHR (0.45) | KDM4ECYP1A2CYP2D6GAATSHR | |
| SCHEMBL18000055 | 0.81 | KDM4E (0.68) | KDM4ECYP1A2CYP2D6GAATSHR | |
| SCHEMBL4447238 | 0.81 | KDM4E (0.68) | KDM4ECYP1A2CYP2D6GAATSHR | |
| SCHEMBL8651089 | 0.81 | KDM4E (0.68) | KDM4ECYP1A2CYP2D6GAATSHR | |
| Magnesium SCHEMBL29732237 | 0.81 | KDM4E (0.68) | KDM4ECYP1A2CYP2D6GAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350249-A | Purification method of 4-methylamino antipyrine | 河北冀衡药业股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-117143020-A | Preparation method of analgin with content of analgin impurity 4-N sodium methylenesulfonate analgin controlled | 河北冀衡药业股份有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-113248440-B | Synthetic method of 4-formamido antipyrine | 河北冀衡药业股份有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-113248440-A | Synthetic method of 4-formamido antipyrine | 河北冀衡药业股份有限公司 | 2021-08-13 | — | — | CN | claimed |
| CN-107817306-B | Method for simultaneously detecting 64 veterinary drug residues in aquatic product | 中山出入境检验检疫局检验检疫技术中心 | 2020-06-19 | — | — | CN | claimed |
| CN-111303036-A | Synthetic method of analgin impurity | 山东新华制药股份有限公司 | 2020-06-19 | — | — | CN | claimed |
| CN-107255686-B | Analysis method for determining multi-veterinary drug residues in aquaculture water | 中山出入境检验检疫局检验检疫技术中心 | 2020-03-27 | — | — | CN | claimed |
| CN-116514718-B | Hybridoma cell strain, analgin residue marker 4-methylamino antipyrine monoclonal antibody secreted by hybridoma cell strain and application of analgin residue marker | 河南农业大学 | 2026-01-30 | — | — | CN | disclosed |
| CN-119350249-A | Purification method of 4-methylamino antipyrine | 河北冀衡药业股份有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-119350249-A | Purification method of 4-methylamino antipyrine | 河北冀衡药业股份有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-117143020-A | Preparation method of analgin with content of analgin impurity 4-N sodium methylenesulfonate analgin controlled | 河北冀衡药业股份有限公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-117143020-A | Preparation method of analgin with content of analgin impurity 4-N sodium methylenesulfonate analgin controlled | 河北冀衡药业股份有限公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-114315723-B | Analgin residual marker hapten and artificial antigen as well as preparation methods and applications thereof | 中国农业大学 | 2023-08-08 | — | — | CN | disclosed |
| EP-1150660-B1 | PHARMACEUTICAL EFFERVESCENT FORMULATION CONTAINING METAMIZOL | HEXAL AG (DE) | 2004-01-21 | — | — | EP | disclosed |
| EP-1150660-A1 | PHARMACEUTICAL EFFERVESCENT FORMULATION CONTAINING METAMIZOL | HEXAL AG (DE) | 2001-11-07 | — | — | EP | disclosed |
| WO-2000066088-A1 | CONTROLLED RELEASE PHARMACEUTICAL PREPARATION CONTAINING METAMIZOLE | HEXAL AG (DE) | 2000-11-09 | — | — | WO | disclosed |
| WO-2000047189-A1 | PHARMACEUTICAL EFFERVESCENT FORMULATION CONTAINING METAMIZOL | HEXAL AG (DE) | 2000-08-17 | — | — | WO | disclosed |
| US-5760216-A | REACTING DRUG SAMPLE WITH SYNTHETIC METALLOPORPHYRIN, OXIDIZING AGENT, SOLVENT TO FORM OXIDATION PRODUCT | ABBOTT LABORATORIES (US) | 1998-06-02 | — | — | US | disclosed |
| EP-0781261-A2 | USE OF SYNTHETIC METALLOPORPHYRINS FOR PREPARATION AND PREDICTION OF DRUG METABOLITES | Abbott Laboratories (US) | 1997-07-02 | — | — | EP | disclosed |
| WO-1996008455-A2 | USE OF SYNTHETIC METALLOPORPHYRINS FOR PREPARATION AND PREDICTION OF DRUG METABOLITES | ABBOTT LABORATORIES (US) | 1996-03-21 | — | — | WO | disclosed |